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Abstract 
Purpose: To improve the oral bioavailability of berberine using a new self-nanoemulsifying drug 
delivery system (SNEDDS).  
Methods: Berberine SNEDDS was designed using solubility studies and phase diagram construction. A 
series of tests were carried out to study the effect of oil content, dilution, and drug loading on particle 
size. The morphology of the nanoemulsion was examined with a transmission electron microscope. 
Subsequently, the optimized berberine SNEDDS was investigated for in vitro release and compared 
with two marketed products (Xiaowei capsules and Beike tablets) 
Results: The optimized formulation, composed of berberine of 6.0 %, castor oil of 18.8 %, Tween 20 of 
37.6 %, and glycerol of 37.6 %, gave a mean particle size of approximately 60 nm, and was not affected 
by dilution. The optimized formulation released 90 % berberine in 20 min, while the reference products, 
Xiaowei capsules and Beike tablets, required 2 h to release 90 % of berberine. 
Conclusion: The optimized formulation of SNEDDS is a potential alternative oral dosage form for 
improving oral absorption of berberine.  
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Self-nanoemulsifying drug delivery systems 
(SNEDDS) are isotropic and thermodynamically 
stable solutions consisting of oil, surfactant, 
cosurfactant and drug that can self-emulsify 
quickly in the stomach aqueous contents. Thus, it 
introduces the drug in solution within nanosized 
oil droplets [1-3]. Being nanosized, SNEDDS not 
only improves drug solubilization but also 
enhances release and absorption properties, due 
to the resulting small droplet size thus providing 
a large interfacial surface area [4-6]. 
 
Berberine is one of the major components of 
Coptis chinensis Franch. It has been clinically 
applied for decades because of its significant 
effect. Berberine, a lipophilic antibacterial agent 
[7], also presents antidiarrhea [8], hypoglycemic 
[9] and antitumor [10] properties. The current 
commercially marketed dosage forms are tablets 
and capsules. Both of these exhibit low and 
erratic oral bioavailability, which is mainly due to 
the poor dissolution of the drug. 
 
The purpose of the present study was to 
formulate an oral delivery system for berberine 
using SNEDDS. The release of berberine from 
the nanoemulsion formulation was compared to 
that of commercially available tablets and 
capsules. 
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Berberine was purchased from Xingren 
pharmaceutical Co., Ltd (Zhengzhou, China). 
Oleic acid, isopropyl myristate, castor oil and cod 
liver oil were purchased from east sea 
pharmaceutical Co., Ltd (Qingdao, China). 
Tween-20, tween-80, OP emulsifier, isopropyl 
alcohol, glycerol, ethanol were purchased from 
Sinopharm Chemical Reagent Co., Ltd (Beijing, 
China). All the other chemicals used were of 
analytical reagent grade. Double-distilled water 
was used throughout the whole study. 
 
Analysis of berberine 
 
The concentration of berberine was determined 
by Agilent 1200 high performance liquid 
chromatograph with a UV detector. The 
chromatographic column was Alltima C18 (250 × 
4.6 mm) with 5 μm particle size. The mobile 
phase consisted of acetonitrile/0.05 M 
KH2PO4/triethylamine (50:50:0.5, v/v/v) at a flow 
rate of 1.0 mL/min. A volume of 20 μL of each 
solution was injected into the HPLC and the 
eluent was monitored at 345 nm. The retention 
time of berberine was 8.3 ± 0.05 min at ambient 
room temperature. The mean calibration curve 
was given by the equation, y = 36.1x - 0.65, r = 
0.9998, where y represents peak area and x 
represents the concentration (ug/mL) of 
berberine. The method was validated for 





The solubility of berberine in various solvents 
was determined as follows: An excess amount of 
berberine was added into 5 mL of each vehicles 
and mixture were kept in sealed vials. After 
capping the tubes, the mixtures were shaken at 
40 °C for 24 h to achieve dissolution equilibrium. 
Then, after standing for 24 h and reaching 
equilibrium at 25 °C, each vial was centrifuged at 
4,000 rpm for 10 min using a centrifuge 
(Eppendorf Centrifuge 5810). Undissolved 
berberine was removed by a membrane filter 
(0.45 μm). The samples were diluted with 
methanol and passed through a 0.22 μm 
cellulose nitrate membrane. The concentration of 
dissolved berberine was determined by HPLC. 
 
Construction of phase diagram 
 
On the basis of solubility study, castor oil was 
selected as a lipid phase, Tween20 and glycerol 
were used as a surfactant and cosurfactant, 
respectively. To determine the concentration of 
components for the existing range of SNEDDS, 
pseudoternary phase diagram was constructed 
using water titration method at ambient 
temperature (25 °C). Surfactant and cosurfactant 
were mixed in different volume ratios (1:3, 1:2, 
1:1, 2:1 and 3:1). Oil and surfactant/co-surfactant 
mixture (O-S/Co) were mixed thoroughly in 
different volume ratios (1:9, 1:8, 1:7, 1:6, 1:5, 1:4, 
1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, 6:1, 7:1, 8:1 and 
9:1). The mixtures of oil, surfactant and co-
surfactant at certain weight ratios were titrated 
with deionized water by drop wise addition under 
gentle addition. Resulting mixture was observed 
for their transparency until titration endpoint 
(turbid was observed). At this point, amount of 
water, oil, surfactant and cosurfactant added 
were noted, and the values were used to 
construct pseudo-ternary plot. Monophasic, 
clear, low viscous and non-birefringent systems 
were considered as nanoemulsion (NE) and 
shown as NE region. 
 
Effect of oily phase content on mean droplet 
size 
 
Based on the results of phase diagram, Km is set 
as 1:1 in Table 1, a series of blank SNEDDS 
were prepared with varying oil content to learn 
the effect of oil content on mean globule size. 
Briefly, oil, surfactant and cosurfactant were 
mixed by stirring to form homogenous mixture. 
Then, 10 mg mixture was dispersed in 500 mL 
double distilled water, droplet size was 
determined immediately after dilution.  
 
Preparation of berberine SNEDDS 
 
Berberine was dissolved into oil in glass vials. 
Surfactant and cosurfactant were accurately 
weighed and were added in. 
 
Table 1: Composition of SNEDDS formulations with varying oil content 
 
Formulation（g） Ingredients 
F1 F2 F3 F4 F5 F6 
Tween20+Glycerol (at ratio of 1:1) 44 42 40 38 36 34 
Castor oil 6 8 10 12 14 16 
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Components were mixed and heated (40–50 °C) 
to form SNEDDS, a homogenous mixture. 
Berberine loaded SNEDDS were stored at room 
temperature for further characterization.  
 
Effect of berberine loading 
 
Effect of berberine loading on physical stability of 
nanoemulsions was studied using optimized 
composition i.e. formulation F3. Accordingly, a 
series of SNEDDS was prepared with varying 
amount of berberine (1.0, 2.0, 4.0, 6.0, 8.0, 10.0 
%). SNEDDS, 10 mg was diluted with 500 mL of 
different media. Mean droplet size of 
nanoemulsions was determined. 
 
Determination of droplets size distribution 
 
The droplet size, size distribution were analysed 
by dynamic light scattering with particle size 
apparatus (Malvern Zetasizer 3000 HS). 
Berberine SNEDDS were diluted with deionized 
water (1:50) in a drop-wise manner at 25 °C 
under gentle shaking. After equilibrium droplet 




Dilution study was done to access the effect of 
dilution on SNEDDS. In this study, Optimized 
formulation was subjected to various 
dilutions(1:20,1:50,1:100) with deionized water, 
then rapid form nanoemulsion, which is clear or 
slightly bluish in appearance or not.  
 
Thermodynamic stability studies of berberine 
SNEDDS 
 
The objective of the phase separation research is 
to evaluate thermodynamic stability of optimized 
berberine SNEDDS. SNEDDS were diluted with 
aqueous medium (1:50) and centrifuged at 4,000 
rpm for 30 min and formulation were observed 
visually for phase separation and drug 
precipitation. 
 
Transmission electron microscopy 
 
The morphology of SNEDDS was observed 
using a transmission electron microscope (TEM; 
JEM-1200EX, Japan). SNEDDS was diluted with 
deionized water at 1:50 and mixed by slight 
shaking. A drop of the diluted samples was 
directly deposited on a holey film grid and then 
stained with one drop of 2 % aqueous solution of 
phosphotungstic acid (PTA), and allowed to dry 
before observation under the electron 
microscope. 
 
In vitro dissolution profile 
 
Berberine SNEDDS was evaluated for in vitro 
release by using USP XXIII apparatus I at 37 ± 
0.5 °C. The revolution speed of the paddle was 
kept constant at 100 rpm, and 500 mL 0.1 M 
hydrochloride solution was chosen as the 
dissolution media. During study, 5 mL aliquots 
removed at 0, 5, 10, 20, 30, 60, 90 and 120 min, 
and filtered through 0.45 μm membrane filters. 
Amount of drug released was determined using 
HPLC method. The removed volume was 




SPSS 18® software was used to analyze the 
data. All results were expressed as the mean ± 
standard deviation. Dissolution data of the 
different formulations were compared by one-
way analysis of variance (ANOVA). P < 0.05 was 




Solubility of berberine in various excipients are 
shown in Table 2. Among oil phase, castor oil 
solubilize maximum amount of berberine, 
whereas in surfactants or cosurfactants, Tween-
20 and glycerol exhibited good solubility for 
berberine. 
 
Table 2: Solubility results of berberine in various excipients (mean ± SD; n = 3) 
 
Oil phase Solubility（mg/mL） Surfactant and cosurfactant Solubility（mg/mL） 
Isopropyl myristate 0.11±0.02 Cremophor EL 1.19±0.16 
Oleic acid 0.26±0.03 Tween-80 0.36±0.14 
Castor oil 0.38±0.04 Tween-20 1.24±0.13 
Cod liver oil 0.16±0.03 Glycerol 2.87±0.22 
  Ethanol 2.84±0.19 
  Isopropyl alcohol 0.43±0.05 
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The pseudo-ternary phase diagrams of the 
formulation composed of castor oil, Tween 20, 
glycerol and water are described.Pseudo-ternary 
plot was constructed using Oringe 6.0 software. 
Figures show ternary phase diagrams for castor 
oil - Tween20 - glycerol systems, respectively. 
Nanoemulsion area was highest at Km = 1. 
Hence, surfactant to cosurfactant ratio was 
maintained at 1:1. The size of nanoemulsion 
region was compared, larger the size, greater is 
the self-nanoemulsification efficiency.  
 
Effects of oil concentration on mean droplet size 
are shown in Fig 1. SNEDDS formulations F1 
and F2 were found rapid to dilution and did not 
show any phase separation after 24 h. From 
phase diagram, it was evident that castor oil – 
Tween20 – glycerol system can incorporate more 
than 20 % w/w of oil phase. However, 
compositions with such high oil content may not 
be necessarily stable. Hence, SNEDDS with 
varying oil content at Km = 1 were formulated to 
identify optimum oil concentration that can yield 
nanoemulsion of desired droplet size. It is 
evident that up to 20 % w/w concentration of 
castor oil (formulations F1, F2, F3), mean globule 
size was < 50 nm. However, increase in oil 
content above 24 % and mean droplet size 
increased considerably. Formulations F5, F6 that 
contained oil phase 28 % and above exhibited 
globule size greater than 100 nm. Based on this 
study, formulation F3 that contained 20 % w/w oil 






















Fig 1: Effect of oil content on mean droplet size (n = 3) 
 
Effect of berberine loading on mean droplet size 
is shown in Fig 2. Droplet size experiments 
showed that incorporation of berberine in 
SNEDDS does not have any impact on droplet 
size when its concentration was up to 6.0 % w/w. 
However, mean globule size increased 
significantly when concentration of berberine was 






















Fig 2: Effect of berberine loading on mean droplet size 
(n = 3) 
 
Accordingly, berberine SNEDDS formulation was 
selected for further experiments and its 
compositions were as follows: berberine 12.8 g, 
castor oil 40 g, Tween 20 80 g and glycerol 80 g. 
 
Optimized berberine SNEDDS were diluted with 
deionized water in a drop-wise manner at 25 °C 
under gentle shaking. After equilibrium droplet 
size was 58.4 nm, polydispersity index was 0.26, 
and zeta potential was -12.9 ± 0.5 mv. 
 
The influence of increasing the dilution factor 
from (1:10, 1:50 and 1:100) was evaluated, they 
all rapidly formed clear nanoemulsion, In all 
cases, increased dilution resulted in the 
nanoemulsion remaining with the same clarity. 
Phase separation and drug precipitation were not 
observed in sample solution during the stability 
studies. 
 
The morphology of the nanoemulsion was 
examined with a transmission electron 
microscope. The droplet on the nanoemulsion 
appears dark with the bright surroundings. TEM 
photographs (Fig 3) further conformed that the 




    Fig 3: TEM photograph 
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In vitro dissolution profile of optimized berberine 
SNEDDS in comparison to its commercial 
capsules (Xiaowei, China) and market tablets 
(Beike, China) in 0.1 M hydrochloride solution is 
shown in Fig 4. SNEDDS release 90 % berberine 
in 20 min in dissolution media, Xiaowei capsules 
and Beike tablets required 2 h to release 90 % of 
berberine (p < 0.05). Dramatic increase in the 
rate of release of berberine from SNEDDS 
compared to commercial capsules and tablets 
can be attributed to its quick dispersability and 






























Fig 4: Release profiles of berberine from various 




As it is important to achieve optimum drug 
loading, solubility study was aimed to identify 
suitable SNEDDS components that possess 
good solubilizing capacity. So the solubility of 
berberine in various solvents was determined. 
 
Self-nanoemulsifying drug-delivery systems offer 
the potential for enhancing the absorption and 
hence the oral bioavailability of lipophilic drugs. 
The primary mechanisms are presenting the drug 
greater surface area or in solubilized form in vivo, 
and increasing mucosal permeability, increasing 
incorporation into lipoproteins, then secreted into 
the lymphatics, which circumvents the liver, thus 
reducing the hepatic first-pass metabolism [11]. 
 
Enhancement of bioavailability of berberine 
SNEDDS compared with Beike tablets and 
Xiaowei capsules may be due to effects of the 
large quantities of surfactant and cosurfactant 
used which include improved mucosal 
permeability, smaller lipid droplets and greater 
surface area. 
In view of the toxicity of Tween 20, it was 
substituted with Cremophor EL. Thus, the 
optimized formulation was as follows: berberine 
(6.0 % w/w), castor oil (18.8 % w/w), Cremophor 
EL (37.6 % w/w) and glycerol (37.6 % w/w). 
When diluted with water (1:100), this modified 
SNEDDS spontaneously formed small particles 
with average droplet size of about 62 nm, 
Dissolution experiments showed that the 





A self-nanoemulsifying drug delivery system for 
berberine has been successfully achieved in this 
study. This delivery system can potentially be 
employed to maximize the antibacterial capacity 
of a drug. The technique used can potentially be 
used also to prepare other solid self-
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